Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05424718 · ClinicalTrials.gov registry record · NA
MyPEEPS Mobile for Young Transgender Men
A NA study of HIV, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 3
- Study locations
NCT05424718: Completed NA study of HIV, sponsored by Columbia University.
NCT05424718 is a NA study of HIV that has completed, run by Columbia University. The registered enrollment target is 80 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (82% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05424718, a NA study of HIV, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 3
- Study locations
Study Summary
The proposed MyPEEPS intervention for young transgender men is a novel and evidence-driven intervention using mobile technology to deliver HIV prevention information to high risk youth. The final product will be the basis for conducting a large-scale efficacy study in this population.
Primary Outcome
Change in self-reported number of condomless receptive anal or vaginal sex acts with sex partners assigned male at birth
Conditions Studied
Interventions
- BEHAVIORAL MyPEEPS Mobile
Study Locations (3)
New York
- Callen-Lorde Community Health Center - New York
- Columbia University - New York
Illinois
- Ann & Robert H. Lurie Children's Hospital Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-06-16 |
| Est. Completion | 2024-03-21 |
| Phase | NA |
What the finished NCT05424718 record still lists
NCT05424718 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 440-participant average among 303 other HIV trials with a reported enrollment target (82% lower).
The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 1 intervention - of which MyPEEPS Mobile is the first listed.
NCT05424718 reports a single indexed study location in New York, Illinois.
Frequently Asked Questions
What is clinical trial NCT05424718 about?
NCT05424718 is a clinical study titled "MyPEEPS Mobile for Young Transgender Men". The proposed MyPEEPS intervention for young transgender men is a novel and evidence-driven intervention using mobile technology to deliver HIV prevention information to high risk youth. The final product will be the basis for conducting a large-scale efficacy study in this population.
What is the current status of trial NCT05424718?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2023-06-16. Estimated completion is 2024-03-21.
What conditions does trial NCT05424718 study?
This clinical trial studies the following conditions: HIV.
What interventions are being tested in trial NCT05424718?
The interventions under investigation include: MyPEEPS Mobile (BEHAVIORAL).
Who is sponsoring clinical trial NCT05424718?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05424718 being conducted?
This trial has 3 study locations across Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05424718's enrollment target sits among peer trials
80 175th of 303 higher than 124 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI